Myriad Genetics

Myriad discovers and commercializes genetic tests that determine the risk of developing disease, assess the risk of disease progression, and guide treatment decisions across medical specialties.

Year Established: 1991 Stock Ticker: MYGN Exchange: NASDAQ

Locations